SCRN1 is a novel marker for prognosis in colorectal cancer.

Abstract

PURPOSE Secernin 1 (SCRN1) is a member of the secernin family and is reported to be a tumor-associated antigen. Previous reports show that SCRN1 is upregulated in gastric cancer cell lines and may be a novel immunotherapy target, whereas its significance in colorectal cancer (CRC) is not fully understood. MATERIALS AND METHODS The present study comprised… (More)
DOI: 10.1002/jso.21459

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics